The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer
Neil J. Shah(Memorial Sloan Kettering Cancer Center), William Oh(Women & Infants Hospital of Rhode Island), George Mellgard(Memorial Sloan Kettering Cancer Center), Jessica E. Hawley(Columbia University Irving Medical Center), Michael J. Morris(The University of Texas Southwestern Medical Center), Jones T. Nauseef(Cornell University), Xiaobo Zhong(Icahn School of Medicine at Mount Sinai), Benjamin A. Gartrell, Himanshu Joshi(Icahn School of Medicine at Mount Sinai), Victor Adorno Febles(VA NY Harbor Healthcare System), Philip W. Kantoff(Dana-Farber Brigham Cancer Center), Bobby Chi-Hung Liaw(Icahn School of Medicine at Mount Sinai), Panagiotis J. Vlachostergios(Cornell University), Vaibhav G. Patel(Icahn School of Medicine at Mount Sinai), Luis A. Pina(Columbia University Irving Medical Center), Daniel H. Kwon(Harvard University), David A. Green(NewYork–Presbyterian Hospital), David R. Wise, Franklin W. Huang(San Francisco VA Medical Center), Qian Qin(Icahn School of Medicine at Mount Sinai), Emily Lin(Montefiore Medical Center), Scott T. Tagawa(Cornell University)
Cited by 11
Related Papers
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
|New England Journal of Medicine|2010|5.5k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Whole-Body Hypothermia for Neonates with Hypoxic–Ischemic Encephalopathy
|New England Journal of Medicine|2005|2.8k
Gene expression correlates of clinical prostate cancer behavior
|Cancer Cell|2002|2.5k